Effective July 1, 2019, the ACGME requires that all programs “provide instruction and experience in pain management if applicable for the specialty including recognition of the signs of addiction.” (Common Program Requirement IV.C.2.)
This requirement directs appropriate residency and fellowship programs to develop evidence-based educational interventions to effectively teach residents and fellows how to:
Prevent addiction wherever possible while effectively treating pain;
Recognize addiction in its earliest stages;
Function effectively in systems of care for effective pain relief and addiction;
Use non-pharmacologic means wherever possible; and,
Participate in clinical trials of new non-opioid pain relief customized to the needs of the clinical disorders of the populations they serve.
The following resources can be used to help programs and institutions identify solutions to meet local needs. The ACGME does not endorse the use of any specific tool or resource.
The New England Journal of Medicine, in partnership with Boston University School of Medicine’s SCOPE of Pain and Area9 Lyceum, has instated a new learning module to assist in furthering education regarding pain management, opioid prescribing, and OUD. The NEJM Knowledge + Pain Management and Opioids module was made available by an educational grant from the Opioid Analgesic Risk Evaluation and Mitigation (REM) Strategies Program Companies.
The ACGME participates in and supports the NAM Action Collaborative on Countering the US Opioid Epidemic. ACGME President and CEO Thomas J. Nasca, MD, MACP is a member of the Steering Committee and co-chairs the Health Professional Education and Training Working Group. The Working Group is currently identifying and highlighting professional practice gaps for health care professionals in relation to acute and chronic pain management and substance use disorders, as well as analyzing current accreditation, certification, and regulatory requirements for the same.
Improving the way opioids are prescribed through clinical practice guidelines can ensure patients have access to safer, more effective chronic pain treatment while reducing the number of people who misuse or overdose from these drugs.
The CDC developed and published the CDC Guideline for Prescribing Opioids for Chronic Pain to provide recommendations for the prescribing of opioid pain medication for patients 18 and older in primary care settings. Recommendations focus on the use of opioids in treating chronic pain outside of active cancer treatment, palliative care, and end-of-life care.